Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999.

Abstract:

:Zosuquidar, which modulates P-glycoprotein (P-gp) with minimal delay of anthracycline clearance, may reverse P-gp-mediated resistance in acute myeloid leukemia without increased toxicity. A total of 449 adults older than 60 years with acute myeloid leukemia or high-risk myelodysplastic syndrome enrolled in a randomized placebo-controlled double-blind trial (Eastern Cooperative Oncology Group 3999). Overall survival was compared between patients receiving conventional-dose cytarabine and daunorubicin and either zosuquidar (550 mg; 212 patients) or placebo (221 patients). Median and 2-year overall survival values were 7.2 months and 20% on zosuquidar and 9.4 months and 23% on placebo, respectively (P = .281). Remission rate was 51.9% on zosuquidar and 48.9% on placebo. All cause mortality to day 42 was not different (zosuquidar 22.2% vs placebo 16.3%; P = .158). In vitro modulation of P-gp activity by zosuquidar and expression of P-gp, multidrug resistance-related protein 1, lung resistance protein, and breast cancer resistance protein, were comparable in the 2 arms. Poor-risk cytogenetics were more common in P-gp(+) patients. P-gp expression and cytogenetics were correlated, though independent prognostic factors. We conclude that zosuquidar did not improve outcome in older acute myeloid leukemia, in part, because of the presence P-gp independent mechanisms of resistance. This trial is registered at www.clinicaltrials.gov as #NCT00046930.

journal_name

Blood

journal_title

Blood

authors

Cripe LD,Uno H,Paietta EM,Litzow MR,Ketterling RP,Bennett JM,Rowe JM,Lazarus HM,Luger S,Tallman MS

doi

10.1182/blood-2010-04-277269

subject

Has Abstract

pub_date

2010-11-18 00:00:00

pages

4077-85

issue

20

eissn

0006-4971

issn

1528-0020

pii

blood-2010-04-277269

journal_volume

116

pub_type

杂志文章,随机对照试验

相关文献

BLOOD文献大全
  • AC133, a novel marker for human hematopoietic stem and progenitor cells.

    abstract::AC133 is one of a new panel of murine hybridoma lines producing monoclonal IgG antibodies (mAbs) to a novel stem cell glycoprotein antigen with a molecular weight of 120 kD. AC133 antigen is selectively expressed on CD34(bright) hematopoietic stem and progenitor cells (progenitors) derived from human fetal liver and b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yin AH,Miraglia S,Zanjani ED,Almeida-Porada G,Ogawa M,Leary AG,Olweus J,Kearney J,Buck DW

    更新日期:1997-12-15 00:00:00

  • Prolonged expression of c-fos suppresses cell cycle entry of dormant hematopoietic stem cells.

    abstract::The proto-oncogene c-fos was transiently upregulated in primitive hematopoietic stem (Lin-Sca-1(+)) cells stimulated with stem cell factor, interleukin-3 (IL-3), and IL-6. To investigate a role of the c-fos in hematopoietic stem cells, we used bone marrow (BM) cells from transgenic mice carrying the c-fos gene under t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Okada S,Fukuda T,Inada K,Tokuhisa T

    更新日期:1999-02-01 00:00:00

  • Activation of plasma complement by perfluorocarbon artificial blood: probable mechanism of adverse pulmonary reactions in treated patients and rationale for corticosteroids prophylaxis.

    abstract::Perfluorocarbons have shown promise as clinical blood substitutes. Although early experience in Japan with one such product--Fluosol-DA--has been uncomplicated, we observed an adverse pulmonary reaction in the first American patient to receive it and know of similar reactions in two other Americans so treated. Postula...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Vercellotti GM,Hammerschmidt DE,Craddock PR,Jacob HS

    更新日期:1982-06-01 00:00:00

  • Structural and functional characterization of a specific antidote for ticagrelor.

    abstract::Ticagrelor is a direct-acting reversibly binding P2Y12 antagonist and is widely used as an antiplatelet therapy for the prevention of cardiovascular events in acute coronary syndrome patients. However, antiplatelet therapy can be associated with an increased risk of bleeding. Here, we present data on the identificatio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-622928

    authors: Buchanan A,Newton P,Pehrsson S,Inghardt T,Antonsson T,Svensson P,Sjögren T,Öster L,Janefeldt A,Sandinge AS,Keyes F,Austin M,Spooner J,Gennemark P,Penney M,Howells G,Vaughan T,Nylander S

    更新日期:2015-05-28 00:00:00

  • Functional characteristics of receptor-bound urokinase on human monocytes: catalytic efficiency and susceptibility to inactivation by plasminogen activator inhibitors.

    abstract::We compared urokinase-type plasminogen activator (u-PA) in fluid phase and u-PA bound with its receptor on human blood monocytes with respect to proteolytic activity and susceptibility to inactivation by the plasminogen activator inhibitors PAI-1 and PAI-2. Receptor-bound u-PA is catalytically twice as efficient as fl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kirchheimer JC,Remold HG

    更新日期:1989-09-01 00:00:00

  • Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-beta: relationship with IL-12 signaling.

    abstract::Interleukin-12 (IL-12) is a cytokine that plays a central role in the control of cell-mediated immunity. We have previously shown that transforming growth factor-beta1 (TGF-beta) inhibitory effects on human primary allogeneic cytotoxicity and proliferative responses interfere with IL-12 pathway. The present study was ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Pardoux C,Ma X,Gobert S,Pellegrini S,Mayeux P,Gay F,Trinchieri G,Chouaib S

    更新日期:1999-03-01 00:00:00

  • Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia.

    abstract::The diagnosis of heparin-induced thrombocytopenia (HIT) requires detection of antibodies to the heparin/platelet factor 4 (PF4) complexes via enzyme-linked immunosorbent assay. Addition of excess heparin to the sample decreases the optical density by 50% or more and confirms the presence of these antibodies. One hundr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-01-262659

    authors: Whitlatch NL,Kong DF,Metjian AD,Arepally GM,Ortel TL

    更新日期:2010-09-09 00:00:00

  • Combination of HOXB4 and Delta-1 ligand improves expansion of cord blood cells.

    abstract::Umbilical cord blood (UCB) is an attractive cell source for hematopoietic cell transplantation (HCT). Here we examine whether the combination of homeobox B4 (HOXB4) and Delta-1 ligand (DL) synergize when used together. Monkey and human UCB CD34(+) cells were transduced with a HOXB4-expressing gammaretroviral vector an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-286062

    authors: Watts KL,Delaney C,Humphries RK,Bernstein ID,Kiem HP

    更新日期:2010-12-23 00:00:00

  • Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.

    abstract::Human transferrin receptor-2 (TFR-2) is a protein highly homologous to TFR-1/CD71 and is endowed with the ability to bind transferrin (TF) with low affinity. High levels of TFR-2 mRNA were found in the liver and in erythroid precursors. Mutations affecting the TFR-2 gene led to hemochromatosis type 3, a form of inheri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0076

    authors: Deaglio S,Capobianco A,Calì A,Bellora F,Alberti F,Righi L,Sapino A,Camaschella C,Malavasi F

    更新日期:2002-11-15 00:00:00

  • Thioredoxin prolongs survival of B-type chronic lymphocytic leukemia cells.

    abstract::Thioredoxin (Trx) is a ubiquitous protein disulfide oxidoreductase with antioxidant, cytokine, and chemotactic properties. Previously, we showed that Trx, in synergy with interleukin 1 (IL-1), IL-2, IL-4, tumor necrosis factor alpha (TNF-alpha), and CD40-ligation induced S-phase entry and mitosis in normal B cells and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nilsson J,Söderberg O,Nilsson K,Rosén A

    更新日期:2000-02-15 00:00:00

  • Chemotherapy-only treatment effects on long-term neurocognitive functioning in childhood ALL survivors: a review and meta-analysis.

    abstract::Therapy for childhood acute lymphoblastic leukemia (ALL) is associated with 5-year survival rates of ∼90% even after largely eliminating cranial radiation. This meta-analysis assesses the long-term neurocognitive functioning after chemotherapy-only regimens among survivors of childhood ALL. We conducted a systematic r...

    journal_title:Blood

    pub_type: 杂志文章,meta分析,评审

    doi:10.1182/blood-2015-02-627414

    authors: Iyer NS,Balsamo LM,Bracken MB,Kadan-Lottick NS

    更新日期:2015-07-16 00:00:00

  • Cervical carotid artery disease in sickle cell anemia: clinical and radiological features.

    abstract::Cervical internal carotid artery (cICA) occlusion is a recognized cause of acute ischemic stroke (AIS) in sickle cell disease (SCD), but the associated clinical and radiologic features are not well described. We reviewed data on cervical magnetic resonance angiography (cMRA) performed prospectively in 67 patients (55 ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2011-03-337915

    authors: Telfer PT,Evanson J,Butler P,Hemmaway C,Abdulla C,Gadong N,Whitmarsh S,Kaya B,Kirkham FJ

    更新日期:2011-12-01 00:00:00

  • Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation.

    abstract::Eighteen patients with relapse of chronic myelogenous leukemia (CML) after allogeneic bone marrow transplantation (BMT) were treated with recombinant human alpha 2a interferon (IFN). Relapse was defined as greater than 90% metaphases containing the Philadelphia chromosome (Ph) and hematologic abnormalities consistent ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Higano CS,Raskind WH,Singer JW

    更新日期:1992-09-15 00:00:00

  • Gene transfer into normal human hematopoietic cells using in vitro and in vivo assays.

    abstract::The ability to transfer new genetic material into human hematopoietic cells provides the foundation for characterizing the organization and developmental program of human hematopoietic stem cells. It also provides a valuable model in which to test gene transfer and long-term expression in human hematopoietic cells as ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dick JE,Kamel-Reid S,Murdoch B,Doedens M

    更新日期:1991-08-01 00:00:00

  • Characterization of the mouse von Willebrand factor promoter.

    abstract::Expression of the von Willebrand factor (vWF) gene is restricted to the endothelial and megakaryocyte lineages. Within the endothelium, expression of vWF varies between different vascular beds. We have previously shown that the human vWF promoter spanning a region between -2182 (relative to the start site of transcrip...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guan J,Guillot PV,Aird WC

    更新日期:1999-11-15 00:00:00

  • Expression of functional interleukin-15 receptor and autocrine production of interleukin-15 as mechanisms of tumor propagation in multiple myeloma.

    abstract::Interleukin-15 (IL-15) induces proliferation and promotes cell survival of human T and B lymphocytes, natural killer cells, and neutrophils. Here we report the constitutive expression of a functional IL-15 receptor (IL-15R) in 6 of 6 myeloma cell lines and in CD38(high)/CD45(low )plasma cells belonging to 14 of 14 pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tinhofer I,Marschitz I,Henn T,Egle A,Greil R

    更新日期:2000-01-15 00:00:00

  • Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.

    abstract::Lumiliximab is a chimeric macaque-human monoclonal antibody to CD23, a protein expressed on virtually all chronic lymphocytic leukemia (CLL) cells. We examined the ability of lumiliximab to mediate apoptosis, antibody-dependent cellular cytotoxicity, and complement-dependent cytotoxicity against primary CLL cells and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-03-082024

    authors: Pathan NI,Chu P,Hariharan K,Cheney C,Molina A,Byrd J

    更新日期:2008-02-01 00:00:00

  • Antibodies targeting surface membrane antigens in patients with chronic graft-versus-host disease.

    abstract::Chronic graft-versus-host disease (cGVHD) after allogeneic hematopoietic stem cell transplant reflects a complex immune response resulting in chronic damage to multiple tissues. Previous studies indicated that donor B cells and the antibodies they produce play an important role in the development of cGVHD. To understa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-08-801001

    authors: Wang KS,Kim HT,Nikiforow S,Heubeck AT,Ho VT,Koreth J,Alyea EP,Armand P,Blazar BR,Soiffer RJ,Antin JH,Cutler CS,Ritz J

    更新日期:2017-12-28 00:00:00

  • Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen.

    abstract::Sepsis and septic shock remain an important medical problem, emphasizing the need to identify novel therapeutic opportunities. Hypovolemic hypotension, coagulation dysfunction, disturbed microcirculation, and multiorgan failure resulting from vascular leakage are often observed in these severe conditions. In the prese...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-10-182527

    authors: Oehmcke S,Shannon O,von Köckritz-Blickwede M,Mörgelin M,Linder A,Olin AI,Björck L,Herwald H

    更新日期:2009-07-09 00:00:00

  • Unmaintained remissions in multiple myeloma.

    abstract::Twenty-eight patients with multiple myeloma responding to prior melphalan-prednisone combinations, but without additional chemotherapy, were followed until relapse. Patients receiving no further treatment had a median survival time similar to that of those receiving indefinite courses of melphalan-prednisone or carmus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alexanian R,Gehan E,Haut A,Saiki J,Weick J

    更新日期:1978-06-01 00:00:00

  • Dynamic clonal analysis of murine hematopoietic stem and progenitor cells marked by 5 fluorescent proteins using confocal and multiphoton microscopy.

    abstract::We demonstrate a methodology for tracing the clonal history of hematopoietic stem and progenitor cells (HSPCs) behavior in live tissues in 4 dimensions (4D). This integrates genetic combinatorial marking using lentiviral vectors encoding various fluorescent proteins (FPs) with advanced imaging methods. Five FPs: Cerul...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-440636

    authors: Malide D,Métais JY,Dunbar CE

    更新日期:2012-12-20 00:00:00

  • T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.

    abstract::The class IA subgroup of phosphoinositide 3-kinase (PI3K) is activated downstream of antigen receptors, costimulatory molecules, and cytokine receptors on lymphocytes. Targeted deletion of individual genes for class IA regulatory subunits severely impairs the development and function of B cells but not T cells. Here w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-038620

    authors: Deane JA,Kharas MG,Oak JS,Stiles LN,Luo J,Moore TI,Ji H,Rommel C,Cantley LC,Lane TE,Fruman DA

    更新日期:2007-04-01 00:00:00

  • Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.

    abstract::An inactivating polymorphism at position 609 in the NAD(P)H:quinone oxidoreductase 1 gene (NQO1 C609T) is associated with an increased risk of adult leukemia. A small British study suggested that NQO1 C609T was associated with an increased risk of infant leukemias with MLL translocations, especially infant acute lymph...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2001-12-0264

    authors: Smith MT,Wang Y,Skibola CF,Slater DJ,Lo Nigro L,Nowell PC,Lange BJ,Felix CA

    更新日期:2002-12-15 00:00:00

  • Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemia.

    abstract::Aberrant expression of Aurora kinases and inactivation of wild-type p53 by Mdm2 overexpression are frequent molecular events in acute myelogenous leukemia (AML), and preclinical data for inhibition of Aurora kinases or Mdm2 are promising. However, it remains largely unknown whether the viability of cells exposed to Au...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-01-128611

    authors: Kojima K,Konopleva M,Tsao T,Nakakuma H,Andreeff M

    更新日期:2008-10-01 00:00:00

  • End-linked homodimers in fibrinogen Osaka VI with a B beta-chain extension lead to fragile clot structure.

    abstract::The authors have identified a 12-residue carboxyl-terminal extension of Lys-Ser-Pro-Met-Arg-Arg-Phe-Leu-Leu-Phe-Cys-Met in a dysfibrinogen derived from a woman heterozygotic for this abnormality and associated with severe bleeding. This extension is due to a T-to-A mutation that creates AAG encoding Lys at the stop (T...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sugo T,Nakamikawa C,Yoshida N,Niwa K,Sameshima M,Mimuro J,Weisel JW,Nagita A,Matsuda M

    更新日期:2000-12-01 00:00:00

  • Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke.

    abstract::Platelets are pivotal to the process of arterial thrombosis resulting in ischemic stroke. Occlusive thrombosis is initiated by the interaction of von Willebrand factor (vWf) and platelet glycoprotein (GP) Ibalpha. Three polymorphisms have been described in GP Ibalpha (Kozak T/C polymorphism, variable number of tandem ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v98.1.36

    authors: Baker RI,Eikelboom J,Lofthouse E,Staples N,Afshar-Kharghan V,López JA,Shen Y,Berndt MC,Hankey G

    更新日期:2001-07-01 00:00:00

  • Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease.

    abstract::Adhesive interactions between circulating sickle red blood cells (RBCs), leukocytes, and endothelial cells are major pathophysiologic events in sickle cell disease (SCD). To develop new therapeutics that efficiently inhibit adhesive interactions, we generated an anti-P-selectin aptamer and examined its effects on cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-285718

    authors: Gutsaeva DR,Parkerson JB,Yerigenahally SD,Kurz JC,Schaub RG,Ikuta T,Head CA

    更新日期:2011-01-13 00:00:00

  • iNKT and memory B-cell alterations in HHV-8 multicentric Castleman disease.

    abstract::Human herpesvirus 8 (HHV-8) is the causative agent of Kaposi sarcoma (KS) and multicentric Castleman disease (MCD), a life-threatening, virally induced B-cell lymphoproliferative disorder. HHV-8 is a B-lymphotropic γ-herpesvirus closely related to the Epstein-Barr virus (EBV). Invariant natural killer T (iNKT) cells a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-719716

    authors: Sbihi Z,Dossier A,Boutboul D,Galicier L,Parizot C,Emarre A,Hoareau B,Dupin N,Marcelin AG,Oudin A,Fieschi C,Agbalika F,Autran B,Oksenhendler E,Carcelain G

    更新日期:2017-02-16 00:00:00

  • TFPI cofactor function of protein S: essential role of the protein S SHBG-like domain.

    abstract::Protein S is a cofactor for tissue factor pathway inhibitor (TFPI), accelerating the inhibition of activated factor X (FXa). TFPI Kunitz domain 3 residue Glu226 is essential for enhancement of TFPI by protein S. To investigate the complementary functional interaction site on protein S, we screened 44 protein S point, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-01-551812

    authors: Reglińska-Matveyev N,Andersson HM,Rezende SM,Dahlbäck B,Crawley JT,Lane DA,Ahnström J

    更新日期:2014-06-19 00:00:00

  • Substrate for endothelial prostacyclin production in the presence of platelets exposed to collagen is derived from the platelets rather than the endothelium.

    abstract::Interactions between vascular endothelial cells and blood platelets have been investigated using a model microcirculation consisting of microcarrier beads colonized with human umbilical vein endothelial cells (HUVECs) and perfused with washed platelet suspensions. To simulate the effects of endothelial desquamation an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chesterman CN,Owe-Young R,Macpherson J,Krilis SA

    更新日期:1986-06-01 00:00:00